PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $625,000 | -25.3% | 252,971 | -4.8% | 0.00% | -100.0% |
| Q3 2020 | $837,000 | +14.7% | 265,661 | +5.9% | 0.00% | 0.0% |
| Q2 2020 | $730,000 | +3.3% | 250,971 | +0.1% | 0.00% | 0.0% |
| Q1 2020 | $707,000 | -25.7% | 250,671 | -14.5% | 0.00% | 0.0% |
| Q4 2019 | $951,000 | +42.4% | 293,171 | -5.2% | 0.00% | 0.0% |
| Q3 2019 | $668,000 | -26.1% | 309,271 | +7.4% | 0.00% | 0.0% |
| Q2 2019 | $904,000 | -54.6% | 287,952 | -46.2% | 0.00% | -50.0% |
| Q1 2019 | $1,990,000 | +8.4% | 534,885 | -15.5% | 0.00% | -33.3% |
| Q4 2018 | $1,836,000 | +13.1% | 633,073 | +2.6% | 0.00% | +50.0% |
| Q3 2018 | $1,623,000 | +14.9% | 616,949 | +2.2% | 0.00% | 0.0% |
| Q2 2018 | $1,412,000 | -47.4% | 603,551 | -33.9% | 0.00% | -50.0% |
| Q1 2018 | $2,686,000 | -19.9% | 913,552 | -25.4% | 0.00% | -20.0% |
| Q4 2017 | $3,354,000 | -8.8% | 1,224,236 | +12.8% | 0.01% | 0.0% |
| Q3 2017 | $3,678,000 | +54.0% | 1,085,093 | +12.2% | 0.01% | +25.0% |
| Q2 2017 | $2,389,000 | +19.2% | 967,100 | +9.5% | 0.00% | +33.3% |
| Q1 2017 | $2,005,000 | +42.5% | 883,300 | +33.1% | 0.00% | +50.0% |
| Q4 2016 | $1,407,000 | -30.7% | 663,500 | +9.5% | 0.00% | -33.3% |
| Q3 2016 | $2,031,000 | +21.1% | 606,200 | +13.5% | 0.00% | 0.0% |
| Q2 2016 | $1,677,000 | +8.4% | 534,100 | +14.9% | 0.00% | +50.0% |
| Q1 2016 | $1,547,000 | +13.7% | 464,700 | +20.9% | 0.00% | 0.0% |
| Q4 2015 | $1,361,000 | -32.2% | 384,400 | -3.7% | 0.00% | -33.3% |
| Q3 2015 | $2,007,000 | -23.6% | 399,000 | -2.3% | 0.00% | -25.0% |
| Q2 2015 | $2,626,000 | -26.0% | 408,400 | -11.2% | 0.00% | -20.0% |
| Q1 2015 | $3,551,000 | 0.0% | 459,950 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $3,551,000 | +10.5% | 459,950 | +6.9% | 0.01% | +25.0% |
| Q3 2014 | $3,214,000 | -18.2% | 430,300 | +6.1% | 0.00% | -20.0% |
| Q2 2014 | $3,927,000 | +15.2% | 405,700 | -2.6% | 0.01% | 0.0% |
| Q1 2014 | $3,410,000 | -9.5% | 416,378 | -6.9% | 0.01% | 0.0% |
| Q4 2013 | $3,767,000 | +17.7% | 447,378 | +11.4% | 0.01% | -16.7% |
| Q3 2013 | $3,201,000 | -1.5% | 401,664 | -4.6% | 0.01% | -14.3% |
| Q2 2013 | $3,251,000 | – | 421,164 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |